WallStSmart

Colgate-Palmolive Company (CL)vsNu Skin Enterprises Inc (NUS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 1206% more annual revenue ($20.38B vs $1.56B). CL leads profitability with a 10.5% profit margin vs 7.0%. NUS appears more attractively valued with a PEG of 0.78. NUS earns a higher WallStSmart Score of 67/100 (B-).

CL

Buy

56

out of 100

Grade: C

Growth: 4.7Profit: 8.5Value: 4.7Quality: 3.3
Piotroski: 3/9

NUS

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 5.5Value: 10.0Quality: 8.5
Piotroski: 5/9Altman Z: 4.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLSignificantly Overvalued (-279.8%)

Margin of Safety

-279.8%

Fair Value

$22.51

Current Price

$85.49

$62.98 premium

UndervaluedFair: $22.51Overvalued
NUSUndervalued (+90.1%)

Margin of Safety

+90.1%

Fair Value

$102.49

Current Price

$7.29

$95.20 discount

UndervaluedFair: $102.49Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 8.8/10
Return on EquityProfitability
49.7%10/10

Every $100 of equity generates 50 in profit

Market CapQuality
$67.75B9/10

Large-cap with strong market position

Operating MarginProfitability
20.4%8/10

Strong operational efficiency at 20.4%

Free Cash FlowQuality
$1.28B8/10

Generating 1.3B in free cash flow

NUS5 strengths · Avg: 9.6/10
P/E RatioValuation
4.5x10/10

Attractively priced relative to earnings

Price/BookValuation
0.4x10/10

Reasonable price relative to book value

EPS GrowthGrowth
103.6%10/10

Earnings expanding 103.6% YoY

Altman Z-ScoreHealth
4.1710/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.788/10

Growing faster than its price suggests

Areas to Watch

CL4 concerns · Avg: 3.3/10
P/E RatioValuation
32.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
1.1%4/10

1.1% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.262/10

Expensive relative to growth rate

NUS3 concerns · Avg: 2.7/10
Market CapQuality
$476.78M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.0%3/10

7.0% margin — thin

Revenue GrowthGrowth
-15.3%2/10

Revenue declined 15.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Market Cap, Operating Margin.

Bull Case : NUS

The strongest argument for NUS centers on P/E Ratio, Price/Book, EPS Growth. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bear Case : CL

The primary concerns for CL are P/E Ratio, EPS Growth, Piotroski F-Score. Debt-to-equity of 147.93 is elevated, increasing financial risk.

Bear Case : NUS

The primary concerns for NUS are Market Cap, Profit Margin, Revenue Growth.

Key Dynamics to Monitor

NUS carries more volatility with a beta of 0.98 — expect wider price swings.

CL is growing revenue faster at 5.8% — sustainability is the question.

CL generates stronger free cash flow (1.3B), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NUS scores higher overall (67/100 vs 56/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Nu Skin Enterprises Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.

Visit Website →

Want to dig deeper into these stocks?